ATE165829T1 - Nootrope wirkstoffe - Google Patents
Nootrope wirkstoffeInfo
- Publication number
- ATE165829T1 ATE165829T1 AT92119554T AT92119554T ATE165829T1 AT E165829 T1 ATE165829 T1 AT E165829T1 AT 92119554 T AT92119554 T AT 92119554T AT 92119554 T AT92119554 T AT 92119554T AT E165829 T1 ATE165829 T1 AT E165829T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- hydrogen atom
- lower alkyl
- heterocyclic ring
- joined together
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title abstract 2
- 230000001777 nootropic effect Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000002947 alkylene group Chemical group 0.000 abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- -1 aromatic amino-substituted compound Chemical class 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000002664 nootropic agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/57—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton
- C07C211/59—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP30207091 | 1991-11-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE165829T1 true ATE165829T1 (de) | 1998-05-15 |
Family
ID=17904557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92119554T ATE165829T1 (de) | 1991-11-18 | 1992-11-16 | Nootrope wirkstoffe |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US5434165A (de) |
| EP (1) | EP0543307B1 (de) |
| AT (1) | ATE165829T1 (de) |
| DE (1) | DE69225381T2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2983141B2 (ja) * | 1993-10-06 | 1999-11-29 | 株式会社三和化学研究所 | 新規化合物及び該化合物を有効成分とする脳機能改善剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4563469A (en) * | 1984-07-20 | 1986-01-07 | Warner-Lambert Company | Derivatives of N-[2-(tetrahydro-3,5-dioxo-1H-pyrrolizin-7a(5H)-yl)ethyl]amine as cognition activators |
| DE3582995D1 (de) * | 1984-10-25 | 1991-07-04 | Hoechst Roussel Pharma | 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel. |
| JPS6222785A (ja) * | 1985-07-23 | 1987-01-30 | Sanwa Kagaku Kenkyusho:Kk | 新規な2−オキソピロリジン化合物及びその塩、その製法並びにこれらを有効成分とする脳機能障害の予防及び治療剤 |
| DE3889302T2 (de) * | 1987-12-03 | 1994-10-20 | Mitsubishi Chem Ind | 9-(Acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde Mittel davon als aktiver Wirkstoff. |
| US4916135A (en) * | 1989-05-08 | 1990-04-10 | Hoechst Roussel Pharmaceuticals Inc. | N-heteroaryl-4-quinolinamines |
-
1992
- 1992-11-13 US US07/976,499 patent/US5434165A/en not_active Expired - Fee Related
- 1992-11-16 EP EP92119554A patent/EP0543307B1/de not_active Expired - Lifetime
- 1992-11-16 DE DE69225381T patent/DE69225381T2/de not_active Expired - Fee Related
- 1992-11-16 AT AT92119554T patent/ATE165829T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0543307A3 (en) | 1993-06-30 |
| DE69225381T2 (de) | 1998-09-03 |
| EP0543307A2 (de) | 1993-05-26 |
| US5434165A (en) | 1995-07-18 |
| EP0543307B1 (de) | 1998-05-06 |
| DE69225381D1 (de) | 1998-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO913750D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
| DK0590919T3 (da) | Terapeutiske midler mod Parkinsons sygdom | |
| HUT44001A (en) | Process for producing new phenoxy-acetamide derivatives and pharmaceutical compositions containing them as active components | |
| HU904912D0 (en) | Process for producing thiazole derivatives | |
| NO813359L (no) | Fremgangsmaate for fremstilling av 1,2,3,4-tetrahydro-isokinolin-3-karboksylsyre-derivater | |
| HUT61742A (en) | Process for producing cyclic amide derivatives and pharmaceutical compositions comprising same | |
| HUT60258A (en) | Aminokumaran derivatives and process for producing aminokumaran derivatives and pharmaceutical compositions comprising such compounds | |
| MY109737A (en) | Treatment and compounds. | |
| ATE123494T1 (de) | Chinolon-derivate und deren salze, verfahren zu deren herstellung und diese enthaltende antibakterielle wirkstoffe. | |
| DE69305276D1 (de) | Arylglycinamidderivate, Verfahren zur deren Herstellung und deren Verwendung zur Therapie der Dysurie | |
| IL97249A0 (en) | Condensed thiazole compounds,their production and use | |
| HUT50349A (en) | Process for production of new cefem-compositions | |
| DE69110828D1 (de) | Heterozyklische Aminderivate, deren Herstellung und deren Verwendung. | |
| FI104071B (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 2,5-dihydro-2,5-diokso-1H-bents£b|atsepiinijohdannaisten valmistamiseksi | |
| ATE196080T1 (de) | Verwendung von diphenylethanderivaten zur herstellung eines arzneimittels zur behandlung von glaukom | |
| ATE165829T1 (de) | Nootrope wirkstoffe | |
| TW278076B (de) | ||
| DK0784973T3 (da) | Quinoxalinderivater til behandling af tinnitus | |
| ATE44741T1 (de) | 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere. | |
| TH19066A (th) | วิธีสำหรับยับยั้งการเพิ่มจำนวนเซลล์กล้ามเนื้อเรียบและภาวะการตีบของหลอดเลือด |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |